Evidence map›Paper›PMID 41684767›Full record

ArticleKardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery2025

Predictors of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) failure: analysis of comorbidities and complications - a 10-year experience.

Artur Barshatskyi, Olga Klementova, Jana Zapletalova, Ondrej Zuscik, Petr Santavy, Zdenek Vyhnak, Jakub Konecny, Marek Vicha, Martin Simek

Abstract read
In one paragraph

Article in Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Artur BarshatskyiDepartment of Cardiovascular and Transplant Surgery, University Hospital Olomouc, Czech Republic.
Olga KlementovaDepartment of Anesthesiology and Intensive Care, University Hospital Olomouc, Czech Republic.
Jana ZapletalovaDepartment of Medical Biophysics, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic.
Ondrej ZuscikDepartment of Cardiovascular and Transplant Surgery, University Hospital Olomouc, Czech Republic.
Petr SantavyDepartment of Cardiovascular and Transplant Surgery, University Hospital Olomouc, Czech Republic.
Zdenek VyhnakFaculty of Medicine, University of Ostrava, Czech Republic.
Jakub KonecnyDepartment of Cardiovascular and Transplant Surgery, University Hospital Olomouc, Czech Republic.
Marek VichaDepartment of Cardiovascular and Transplant Surgery, University Hospital Olomouc, Czech Republic.
Martin SimekDepartment of Cardiovascular and Transplant Surgery, University Hospital Olomouc, Czech Republic.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Extracorporeal membrane oxygenation (ECMO) is a rescue method in the treatment of severe cardiac and/or respiratory failure in patients with different etiological factors of this failure and also of different ages. The question of ECMO support of patients has arisen more frequently recently, as a result of the expansion of the indication criteria for this support and the increase in the contingent of patients with severe cardiac and/or respiratory failure. Material and methods: A retrospective study was performed in patients with veno-arterial ECMO (VA-ECMO) support for cardiac or cardiorespiratory failure over a 10-year period at a single ECMO center. In this study, comorbidities and peri- and post-procedural complications were analyzed in search of predictors of failure of the method. Furthermore, the composition of treated patients was analyzed according to the indication for support and known comorbidities at the time the support was indicated. Results: The largest indication group among patients supported by VA-ECMO was those with acute coronary syndrome ( Conclusions: Analysis of the results shows a correlation of survival with the incidence of infection at the cannulation site and limb ischemia. Survival at 30 days correlated with multiorgan dysfunction syndrome, cerebral edema and cannulation site infection. Survival at 90 days correlated with cannulation site infection. Survival at 12 months correlated with limb ischemia and cannulation site infection. Of the comorbidities known at the time of indication, only atrial fibrillation was correlated with 12-month survival and hospitalization mortality (significance level

Indexed as

comorbiditiescomplicationsextracorporeal membrane oxygenation

Identifiers

PMID41684767
PMCPMC12892182

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.